Name
BioAgilytix
What We Do
Don't miss our Lunch Symposium, “Overcoming Challenges for Advanced Therapeutics: Case Studies on Navigating the Unique Bioanalytical and CMC Characterization Landscape of Cell and Gene Therapies” on Wednesday, May 14th, from 12:15 to 1:15 PM in rooms 383-385. Scientific Officers Lynn Kamen, PhD, and Jessica Weaver, MRes, will co-present and be available to answer questions after the symposium and at our booth.
BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. With over a decade of gene and cell therapy experience, we have worked with over a hundred partners to build the right bioanalytical package based on the current regulatory standards, from GMP, GLP, GCP, to CLIA and IDE/IVDR.
We provide the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services. Our labs provide immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, which eliminates the need for multiple providers, ensuring efficient delivery of data for your therapeutic study.
We operate state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.
BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. With over a decade of gene and cell therapy experience, we have worked with over a hundred partners to build the right bioanalytical package based on the current regulatory standards, from GMP, GLP, GCP, to CLIA and IDE/IVDR.
We provide the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services. Our labs provide immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, which eliminates the need for multiple providers, ensuring efficient delivery of data for your therapeutic study.
We operate state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.
Website
Categories (1000)
Assay Development, Cell Therapy, Gene Therapy
Address
2300 Englert Dr.
27713
27713